Kamposioras K., Ntellas P., Nikolaou M., Germetaki T., Gazouli I., Dadouli K., Zarkavelis G., Amylidi A.-L., Tolia M., Mauri D. (2021)
Background: The therapeutic role of immune checkpoint inhibitors (ICIs) has represented the cutting edge of clinical research in upper gastrointestinal (GI) malignancies, with these agents now included in the armamentarium ...